The compounds presented here evoked their potential antitumor activity by different mechanisms, such as cell-cycle arrest, anti-inflammatory activity, apoptosis, induction of ER stress, and interaction with many different targets involved in cancer development, such as mitochondrial membrane, PARP, cytochrome c, Akt, and caspases (Figure 1). The gene discussed is CYCS; the disease is cancer.